در این صفحه تعداد 118 مقاله تخصصی درباره بعد از که در نشریه های معتبر علمی و پایگاه ساینس دایرکت (Science Direct) منتشر شده، نمایش داده شده است. برخی از این مقالات، پیش تر به زبان فارسی ترجمه شده اند که با مراجعه به هر یک از آنها، می توانید متن کامل مقاله انگلیسی همراه با ترجمه فارسی آن را دریافت فرمایید. در صورتی که مقاله مورد نظر شما هنوز به فارسی ترجمه نشده باشد، مترجمان با تجربه ما آمادگی دارند آن را در اسرع وقت برای شما ترجمه نمایند.
مقالات ISI بعد از (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند. در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بعد از; dose escalation; dose optimization; psoriasis; secukinumab; AE; adverse event; PASI; Psoriasis Area and Severity Index; PASI-75; 75% reduction from baseline PASI score; PGA; Physician Global Assessment;
Keywords: بعد از; ISS; itch severity scale; NRS; numeric rating scale; PASI; Psoriasis Area and Severity Index; QoL; quality of life; VAS; visual analog scale;
Keywords: بعد از; discontinuation; methotrexate; moderate-to-severe psoriasis; Psoriasis Area and Severity Index (PASI); prediction; response; AUC; area under the curve; DLQI; Dermatology Life Quality Index; ITT; intent-to-treat; PASI; Psoriasis Area and Severity Index; PA
Keywords: بعد از; psoriasis; psychodermatology; quality of life; skin lesions; social rejection; social stigma; stigmatization; DLQI; Dermatology Life Quality Index; FSQ; Feelings of Stigmatization Questionnaire; HRQoL; health-related quality of life; PASI; Psoriasis Area
Keywords: بعد از; ACR; American College of Rheumatology; bDMARDs; biologic disease-modifying antirheumatic drugs; DMARDs; disease-modifying antirheumatic drugs; EULAR; European League Against Rheumatism; GRAPPA; Group for Research and Assessment of Psoriasis and Psoriatic
Keywords: بعد از; AUC; area under the receiver operating characteristic curve; PASI; Psoriasis Area and Severity Index; PASI75; at least 75% reduction in Psoriasis Area and Severity Index score; UPSC; universal psoriasis skin classifier;
Keywords: بعد از; apremilast; cost per responder; cost-effectiveness; indirect comparison; methotrexate; moderate to severe psoriasis; number needed to treat; Psoriasis Area and Severity Index; AAD; American Academy of Dermatology; CI; confidence interval; FDA; Food and Dr
Keywords: بعد از; etanercept; long-term safety; open-label; pediatric population; plaque psoriasis; AE; adverse event; CDC; Centers for Disease Control and Prevention; FDA; Food and Drug Administration; HRQOL; health-related quality of life; JIA; juvenile idiopathic arthri
Keywords: بعد از; Dermatology Life Quality Index; health-related quality of life; patient-reported outcomes; plaque psoriasis; Psoriasis Area and Severity Index; Psoriasis Symptom Inventory; static Physician Global Assessment; DLQI; Dermatology Life Quality Index; HRQoL; h
Keywords: بعد از; Psoriasis; Comorbilidades; Criterios de gravedad: BSA; Body Surface Area; PASI; Psoriasis Area and Severity Index; DLQI; Dermatology Life Quality Index; Fototerapia; Retinoides; Metotrexato; Ciclosporina; Terapia biológica;
Keywords: بعد از; ACR; American College of Rheumatology; ADAb; anti-drug antibody; ADCC; antibody-dependent cell-mediated cytotoxicity; AIFA; Italian Medicines Agency; CDC; complement-dependent cytotoxicity; CHMP; Committee for Medicinal Products for Human Use; DAS28; 28-j
Keywords: بعد از; atopic dermatitis; baricitinib; eczema; JAK inhibitor; ruxolitinib; systemic therapy; tofacitinib; CPK; creatine phosphokinase; Cr; creatinine; EASI; Eczema Area and Severity Index; JAK; Janus kinase; PASI; Psoriasis Area and Severity Index; STAT; signal
Keywords: بعد از; ASO; anti-streptolysin O; CA; Candida albicans; CLA; cutaneous lymphocyte-associated antigen; CLA-/Epi; co-cultures of CLA- T cells and autologous epidermal cells; CLA+/Epi; co-cultures of CLA+ T cells and autologous epidermal cells; DC; dendritic cel
Keywords: بعد از; cumulative benefit; itching; pain; psoriasis; quality of life; scaling; secukinumab; AUC; area under the curve; CI; confidence interval; DLQI; Dermatology Life Quality Index; HRQoL; health-related quality of life; MCID; minimal clinically important differ
Keywords: بعد از; anti-TNF; anti-tumor necrosis factor; certolizumab pegol; chronic plaque psoriasis; CIMPACT; etanercept; phase 3 trial; CZP; certolizumab pegol; FcRn; neonatal Fc receptor; PASI; Psoriasis Area and Severity Index; PASI 50; â¥50% reduction in PASI from
Keywords: بعد از; ApoE; apolipoprotein E; IMQ; imiquimod; TC; total cholesterol; TG; triglycerides; LDL; low density lipoproteins; HDL; high density lipoproteins; PASI; psoriasis area and severity index; PPARs; peroxisome proliferator activated receptors; IL; interleukin;
Keywords: بعد از; ABP 501; adalimumab; biosimilar; efficacy; equivalence; psoriasis; safety; ADA; antidrug antibody; CI; confidence interval; PASI; Psoriasis Area and Severity Index; PASI 50; 50% or more improvement in Psoriasis Area and Severity Index score from baseline;
Keywords: بعد از; PBMC; peripheral blood mononuclear cells; TCM; central memory T cells; TEM; effector memory T cells; TEFF; effector T cells; PASI; Psoriasis Area and Severity Index; CRP; C-reactive protein; CLA; cutaneous lymphocyte-associated antigen; Th1; T helper 1 ce
Keywords: بعد از; psoriasis; secukinumab; ustekinumab; clinical trial; Psoriasis Area and Severity Index (PASI); efficacy; safety; AE; adverse event; DLQI; Dermatology Life Quality Index; EQ-5D-3L; EuroQoL 5-Dimension Health Questionnaire 3-level version; HAQ-DI; Health As